Doppelherz® Beauty Lifting Complex with Hyaluronic Acid

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.001353.03.17
Date of registration and renewal:21.03.2017
Dosage form: & nbspCapsules with a mass of 565 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp Supplements that primarily affect the processes of tissue metabolism BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing selenium Supplements that support the functions of the immune system Supplements antioxidants Supplements that affect energy metabolism Supplements that support the function of the cardiovascular system Supplements that promote the normalization of lipid metabolism Supplements supporting the functions of the musculoskeletal system BAA, reducing the risk of violations of carbohydrate metabolism
Composition: & nbspHyaluronic acid, ascorbic acid, beta-carotene, vitamin E, calcium pantothenate, zinc carbonate, biotin, sodium selenate, calcium hydrogenorthophosphate, colloidal silicon dioxide, magnesium stearate, gelatin, purified water, titanium dioxide.
Scope: & nbsp
For sale to the population through the pharmacy network and specialized shops, departments of the trade network as a biologically active food additive - an additional source of biotin, pantothenic acid, vitamin E, beta-carotene, vitamin C, hyaluronic acid, zinc, selenium.
Suggested Usage: & nbspAdults take 1 capsule daily with meals. Duration of admission is 1 month.After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance to components, pregnant and lactating women.
Special instructions:Before use, consult a physician.
Shelf life:3 years.
Storage conditions:Store in a dry place at a temperature of no higher than 25 ° C.
Research protocols:
ATreplacing the certificate of state registration No. RU.77.99.11.003.Е.006680.08.14 of August 14, 2014, the expert opinion of the Federal Security Service of the Federal Frontier Guard and Federal Service for Supervision of Consumer Rights Protection No. 10-2 ФЦ / 1719 of 24.04.2012.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp29.04.2017
Instructions
Up